Trial
NCT04418648
Study of Toripalimab for Limited-Stage Small Cell Lung Cancer Following Concurrent Chemoradiotherapy
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Sun Yat-sen University
Collaborators
The First Affiliated Hospital of Guangzhou Medical University; Guangzhou Panyu Central Hospital
Condition
Small Cell Lung Cancer Limited Stage
Intervention
Toripalimab
Why stopped
Since the interim results of the ADRIATIC trial presented at the ASCO Annual Meeting in June 2024, the design of the control group is no longer consistent with current clinical practice.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-02-04